Witnessed are the passage of the year 2022, as well as the fruits of NeuroXess’s innovation and development. Under countless stars in the sky, the company keeps stepping forward, steady and fast. By the year’s end, NeuroXess has claimed several annual awards and retained approval from the industry and the market by virtue of its leading technical R&D and comprehensive overall strength.
TMTPOST
2022 EDGE Awards
Frontier Technology Enterprise Award
The selected companies are all hardcore science and technology companies that have received much attention in 2022. Technology companies representing advanced manufacturing, robotics, semiconductor chips, new materials, smart driving, and future virtual technology are rapidly emerging, exploring major technological breakthroughs and promoting the application of technology for industrial development.
Iyiou Health
CHS 2022
Top 10 Innovative Enterprises in China’s Health Industry
In retrospection of 2022 at the year’s end, digital technology keeps reconfiguring the boundaries of health care and creating new industry increments amidst flaring challenges. In the wave of digital health care, entrepreneurs are following the trend to share prosperity with the times.
GeekPark
2022 InnoForce 50
The list recognizes Chinese companies/institutions that have brought innovation and breakthroughs to pan-computer science and its intersectional fields in the past year. The InnoForce 50 is a lens through which to view future technology trends, and we see the power of cutting-edge technologies such as quantum computing, commercial spaceflight, Brain-Computer Interface, synthetic biology, and even controlled nuclearfusion.
NeuroXess won the favor of the capital market within one year after its establishment, which can be proved by the two rounds of a billion RMB scale of financing. At the beginning of the year in January, just 3 months after its establishment, NeuroXess announced the completion of a 97 million RMB angel round and Pre-A round of financing. At the end of the year in December, it officially announced the completion of Series A financing totaling hundreds of millions of yuan.
According to the CEO of NeuroXess, Phoenix Peng, 2022 is an extremely extraordinary year. The tough market environment just tests and demonstrates the strength of companies. NeuroXess will insist on driving huge changes in the medical technology industry and helping the development of brain science in China.
发表回复